Severe Combined Immunodeficiency: Knowledge and Information Needs Among Healthcare Providers.
healthcare providers
information needs
knowledge gaps
newborn screening
rare genetic conditions
severe combined immunodeficiency
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
10
2021
accepted:
27
01
2022
entrez:
10
3
2022
pubmed:
11
3
2022
medline:
11
3
2022
Statut:
epublish
Résumé
Severe combined immunodeficiency (SCID) is a group of life-threatening genetic disorders responsible for severe dysfunctions of the immune system. Despite the expansion of newborn screening in the U.S., there are gaps in healthcare providers' knowledge of SCID. We recruited 277 U.S. healthcare providers for an online survey. The survey assessed providers' experience with SCID patients, knowledge about SCID, and needs and preferred formats for SCID-related informational resources. We examined differences between providers who have seen 2 or more patients with SCID (SCID provider group) and those who have seen 0-1 SCID patients (non-SCID provider group). Overall, 210 (75.8%) providers were included in the non-SCID provider group, and 121 (57.6%) of these providers were pediatricians. Compared to the SCID provider group, non-SCID provider group reported lower mean rating of SCID knowledge (x̄ = 4.8 vs. x̄ = 8.6, Based on their experience with treating SCID patients, providers have varying levels of SCID knowledge and different informational needs. For providers who have encountered few SCID patients, informational needs start early, usually immediately after receiving a positive newborn screening result. These findings provide useful direction for the development and preferred outlets for receiving SCID-related information, with some variations between different types of providers. Results from this study will serve as a guide for creating relevant and accessible SCID resources for providers who can utilize them to improve care for SCID patients.
Sections du résumé
Background
UNASSIGNED
Severe combined immunodeficiency (SCID) is a group of life-threatening genetic disorders responsible for severe dysfunctions of the immune system. Despite the expansion of newborn screening in the U.S., there are gaps in healthcare providers' knowledge of SCID.
Methods
UNASSIGNED
We recruited 277 U.S. healthcare providers for an online survey. The survey assessed providers' experience with SCID patients, knowledge about SCID, and needs and preferred formats for SCID-related informational resources. We examined differences between providers who have seen 2 or more patients with SCID (SCID provider group) and those who have seen 0-1 SCID patients (non-SCID provider group).
Results
UNASSIGNED
Overall, 210 (75.8%) providers were included in the non-SCID provider group, and 121 (57.6%) of these providers were pediatricians. Compared to the SCID provider group, non-SCID provider group reported lower mean rating of SCID knowledge (x̄ = 4.8 vs. x̄ = 8.6,
Conclusion
UNASSIGNED
Based on their experience with treating SCID patients, providers have varying levels of SCID knowledge and different informational needs. For providers who have encountered few SCID patients, informational needs start early, usually immediately after receiving a positive newborn screening result. These findings provide useful direction for the development and preferred outlets for receiving SCID-related information, with some variations between different types of providers. Results from this study will serve as a guide for creating relevant and accessible SCID resources for providers who can utilize them to improve care for SCID patients.
Identifiants
pubmed: 35265562
doi: 10.3389/fped.2022.804709
pmc: PMC8899266
doi:
Types de publication
Journal Article
Langues
eng
Pagination
804709Informations de copyright
Copyright © 2022 Kutsa, Gwaltney, Creamer and Raspa.
Déclaration de conflit d'intérêts
AC was employed by Immune Deficiency Foundation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Immunol. 2011 Jan;138(1):3-8
pubmed: 21035402
Community Genet. 2006;9(4):260-7
pubmed: 17003536
JAMA. 2014 Aug 20;312(7):729-38
pubmed: 25138334
Pediatrics. 2006 Nov;118(5):1836-41
pubmed: 17079552
BMC Med Inform Decis Mak. 2005 Oct 14;5:34
pubmed: 16225686
Am J Med Genet A. 2006 Nov 1;140(21):2305-11
pubmed: 17022079
Am J Intellect Dev Disabil. 2013 Jul;118(4):284-93
pubmed: 23937370
Acad Pediatr. 2009 Mar-Apr;9(2):114-7
pubmed: 19329102
Genet Med. 2005 Nov-Dec;7(9):605-10
pubmed: 16301861
Front Immunol. 2020 May 06;11:885
pubmed: 32435251
J Allergy Clin Immunol. 2019 Jun;143(6):2271-2278
pubmed: 31178019
Semin Perinatol. 2015 Apr;39(3):194-205
pubmed: 25937517
Intractable Rare Dis Res. 2019 Nov;8(4):252-259
pubmed: 31890452
J Genet Couns. 2016 Oct;25(5):892-900
pubmed: 27084745
Clin Pediatr (Phila). 2015 Jan;54(1):67-75
pubmed: 25104730
Heart Lung Circ. 2014 Apr;23(4):309-13
pubmed: 24054707
Ital J Pediatr. 2015 May 29;41:41
pubmed: 26021374
Orphanet J Rare Dis. 2020 Jan 17;15(1):18
pubmed: 31952528
Am J Perinatol. 2011 Mar;28(3):169-76
pubmed: 20830657
Int J Neonatal Screen. 2018 Dec 31;5(1):3
pubmed: 33072963
J Inherit Metab Dis. 2005;28(6):819-24
pubmed: 16435173